"Balancing Statin Risks: Diabetes Concerns vs. Cardiovascular Benefits"
A new analysis of 23 randomized trials involving 154,664 individuals suggests that statin therapy increases the risk of developing type 2 diabetes, particularly among those with elevated glucose levels, but the cardiovascular benefits of statins outweigh this risk. The study found that statins raise glucose levels and the risk of diabetes, but the benefits on major vascular events outweigh these risks. The authors recommend continued screening for diabetes and associated risk factors, as well as monitoring glycemic control according to current clinical guidelines. The findings emphasize the importance of holistic care and promoting strategies to prevent or delay diabetes in individuals prescribed statins.